According to Anixa Biosciences's latest financial reports the company's current earnings (TTM) are -$12.07 M. In 2023 the company made an earning of -$11.02 M an increase over its 2022 earnings that were of -$13.88 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -$12.07 M | 9.56% |
2023 | -$11.02 M | -20.64% |
2022 | -$13.88 M | 5.63% |
2021 | -$13.14 M | 31.64% |
2020 | -$9.98 M | -13.02% |
2019 | -$11.48 M | -19.63% |
2018 | -$14.28 M | 216.57% |
2017 | -$4.51 M | 0.27% |
2016 | -$4.5 M | 384.99% |
2015 | -$0.93 M | -88.89% |
2014 | -$8.35 M | -7% |
2013 | -$8.98 M | 112.14% |
2012 | -$4.23 M | -15.9% |
2011 | -$5.03 M | -4.19% |
2010 | -$5.25 M | |
2006 | -$7.63 M | 70.8% |
2005 | -$4.47 M | 32.71% |
2004 | -$3.37 M | 7.88% |
2003 | -$3.12 M | |
2001 | -$3.61 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 818.27% | ๐บ๐ธ USA |